CD38-mediated Ca(2+) Signaling Contributes to Glucagon-induced Hepatic Gluconeogenesis
Authors
Affiliations
CD38 is a multifunctional enzyme for the synthesis of Ca(2+) second messengers. Glucagon promotes hepatic glucose production through Ca(2+) signaling in the fasting condition. In this study, we investigated the role of CD38 in the glucagon signaling of hepatocytes. Here, we show that glucagon induces cyclic ADP-ribose (cADPR) production and sustained Ca(2+) increases via CD38 in hepatocytes. 8-Br-cADPR, an antagonistic cADPR analog, completely blocked glucagon-induced Ca(2+) increases and phosphorylation of cAMP response element-binding protein (CREB). Moreover, glucagon-induced sustained Ca(2+) signals and translocation of CREB-regulated transcription coactivator 2 to the nucleus were absent and glucagon-induced glucose production and expression of glucose-6-phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase (Pck1) are remarkably reduced in hepatocytes from CD38(-/-) mice. Furthermore, in the fasting condition, CD38(-/-) mice have decreased blood glucose and hepatic expression of G6Pase and Pck1 compared to wild type mice. Our data suggest that CD38/cADPR-mediated Ca(2+) signals play a key role in glucagon-induced gluconeogenesis in hepatocytes, and that the signal pathway has significant clinical implications in metabolic diseases, including type 2 diabetes.
CD38/cADPR-mediated calcium signaling in a human myometrial smooth muscle cell line, PHM1.
Dogan S, Walseth T, Guvenc Tuna B, Ucar E, Kannan M, Deshpande D IUBMB Life. 2024; 76(12):1223-1233.
PMID: 39135342 PMC: 11580371. DOI: 10.1002/iub.2904.
Benzi A, Heine M, Spinelli S, Salis A, Worthmann A, Diercks B Front Endocrinol (Lausanne). 2024; 14:1251351.
PMID: 38390373 PMC: 10882718. DOI: 10.3389/fendo.2023.1251351.
Wang L, Li Q, Wen K, Zhao Q, Zhang Y, Zhao J Int J Mol Sci. 2023; 24(21).
PMID: 37958991 PMC: 10650707. DOI: 10.3390/ijms242116008.
Rah S, Joe Y, Park J, Ryter S, Park C, Chung H Exp Mol Med. 2023; 55(7):1492-1505.
PMID: 37394593 PMC: 10393965. DOI: 10.1038/s12276-023-01034-9.
Clinical Pharmacokinetics and Pharmacodynamics of Daratumumab.
Kim K, Phelps M Clin Pharmacokinet. 2023; 62(6):789-806.
PMID: 37129750 PMC: 10760401. DOI: 10.1007/s40262-023-01240-8.